UnknownNot Applicable

NT-proBNP and Troponin I in Dengue Children

Vietnam90 participantsStarted 2021-04-02

Plain-language summary

To discribe concentration of NT-proBNP and Troponin I in Dengue hemorrhagic shock children, in correlation between concentration of NT-proBNP and troponin I with total fluid admission, respiratory support, using inotrope and vasopressor using.

Who can participate

Age range1 Month – 18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Dengue shock children who admitted to ICU Exclusion Criteria: * Excluding the cases of children with cardiovascular disease, hyperthyroidism, taking drugs such as insulin, steroid, estrogen, growth hormone, thyroid hormone

What they're measuring

Concentration of NT-proBNP

Timeframe: 10 days

Concentration of Troponin I

Timeframe: 10 days

Trial details

NCT IDNCT04837430

SponsorLe Phuoc Truyen

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-12-31

Contact for this trial

Le P. Truyen, MD

+84 903640025 dr.letruyen@ump.edu.vn

View on ClinicalTrials.gov More Dengue Shock Syndrome trials